Patient P-01434

Synthetic patientNBL-101 · Day 116 · 25–34 · M · baseline S18Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Improving

GI state

Favorable

Inflammatory state

Improving

Nutritional resilience

Favorable

Discontinuation risk

14%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S18

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity-6
Inflammatory activity-5
Treatment adherence+3
GI instability-2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

17/100

improving · -4.3 vs previous 14 d

Toxicity

Blood

20.8/100

stable · +0.0 vs previous 14 d

Sleep quality

Wearable

57.2/100

improving · +2.6 vs previous 14 d

Energy level

Daily log

5.8/10

stable · +0.0 vs previous 14 d

Stress level

Daily log

4.5/10

improving · -0.5 vs previous 14 d

Steps

Wearable

10,665

improving · +439 vs previous 14 d

Adherence

Companion

90.4 %

improving · +5.2 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 75 from the failing basin, 25 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Keep simple carbs low
GI +4.2 next day on high-intake days · n 18

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Simple carbohydrates
+4.2detractor · 95%
Dietary fat load
-1.3no signal · 29%
Insoluble fibre
-1.3no signal · 29%
Histamine load
-1no signal · 21%
Spicy / capsaicin
+0.7no signal · 15%
Alcohol
-0.5no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Poor metabolizer
Higher exposure at standard dose

Microbiome

Shannon diversity 2.8 · butyrate capacity 59/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 33 ms
Sleep: 7.7 h
Steps: 9,904
Resting HR: 66 bpm

Daily log: GI score 17, nutritional resilience 62, adherence 90.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01804	47%	S19	AD-05	improved	61
P-01541	39%	S09	AD-05	no change	43
P-01377	37%	S11	AD-05	no change	42
P-01483	37%	S14	AD-05	no change	35
P-01679	34%	S12	AD-05	no change	39
P-01773	29%	S05	AD-05	improved	27
P-01350	36%	S19	BR-03	no change	34
P-01313	34%	S01	BR-03	improved	32
P-01468	34%	S06	BR-03	no change	41
P-01689	34%	S13	BR-03	no change	50
P-01450	31%	S09	BR-03	no change	36
P-01329	27%	S08	BR-03	improved	79